Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction von Tenenbaum, Alexander, Fisman, Enrique Z

Volltext

Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor von Tenenbaum, Alexander, Klempfner, Robert, Fisman, Enrique Z

Volltext

Professor Alexander Tenenbaum: obituary von Fisman, Enrique

Volltext

Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention? von Tenenbaum, Alexander, Fisman, Enrique Z

Volltext

The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect von Fisman, Enrique Z, Tenenbaum, Alexander

Volltext

Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease? von Fisman, Enrique Z, Tenenbaum, Alexander

Volltext

Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons von Tenenbaum, Alexander, Motro, Michael, Fisman, Enrique Z

Volltext

The ubiquitous interleukin-6: a time for reappraisal von Fisman, Enrique Z, Tenenbaum, Alexander

Volltext

Antidiabetic treatment with gliptins: focus on cardiovascular effects and outcomes von Fisman, Enrique Z, Tenenbaum, Alexander

Volltext

"The metabolic syndrome... is dead": these reports are an exaggeration von Tenenbaum, Alexander, Fisman, Enrique Z

Volltext

A cardiologic approach to non-insulin antidiabetic pharmacotherapy in patients with heart disease von Fisman, Enrique Z, Tenenbaum, Alexander

Volltext

Omega-3 polyunsaturated fatty acids supplementation in patients with diabetes and cardiovascular disease risk: does dose really matter? von Tenenbaum, Alexander, Fisman, Enrique Z

Volltext

Effects of a vildagliptin/metformin combination on markers of atherosclerosis, thrombosis, and inflammation in diabetic patients with coronary artery disease von Klempfner, Robert, Leor, Jonathan, Tenenbaum, Alexander, Fisman, Enrique Z, Goldenberg, Ilan

Volltext

"If it ain't broke, don't fix it": a commentary on the positive-negative results of the ACCORD Lipid study von Tenenbaum, Alexander, Fisman, Enrique Z

Volltext

Mirroring the CANTOS revolution: is anti-inflammatory therapy for diabetes just around the corner? von Tenenbaum, Alexander, Fisman, Enrique Z

Volltext

Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins von Tenenbaum, Alexander, Fisman, Enrique Z, Motro, Michael, Adler, Yehuda

Volltext

Metabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR) von Tenenbaum, Alexander, Fisman, Enrique Z, Motro, Michael

Volltext

Impact of type 2 diabetes mellitus on short- and long-term mortality after coronary artery bypass surgery von Kogan, Alexander, Ram, Eilon, Levin, Shany, Fisman, Enrique Z, Tenenbaum, Alexander, Raanani, Ehud, Sternik, Leonid

Volltext

Type 2 diabetes mellitus increases the mortality risk after acute coronary syndrome treated with coronary artery bypass surgery von Ram, Eilon, Sternik, Leonid, Klempfner, Robert, Iakobishvili, Zaza, Fisman, Enrique Z., Tenenbaum, Alexander, Zuroff, Elchanan, Peled, Yael, Raanani, Ehud

Volltext

Optimal revascularization in diabetes after the FREEDOM trial: were the controversies finally settled? von Tenenbaum, Alexander, Fisman, Enrique Z

Volltext